Webinar: Herpes zoster in the immunocompromised patient
01 October 2024 - 01 October 2024, 7:30 PM - 8:45 PM
Type
Continuing Medical Education
Free webinar for primary care professionals. Joan Ingram and Edwin Reynolds on the role of the vaccine Shingrix for those with immunocompromise. The funding for the recombinant adjuvanted herpes zoster vaccine Shingrix has been broadened to include some with immunocompromise from 18 years of age.
In this webinar, the role of the vaccine for those with immunocompromise will be reviewed. Topics will include the epidemiology and clinical picture of herpes zoster, with an emphasis on those with different immunocompromising conditions.
The safety and effectiveness of the vaccine Shingrix will be reviewed with a focus on those with immunocompromise.
Attendance to this webinar is eligible for 1 CPD point.
In this webinar, the role of the vaccine for those with immunocompromise will be reviewed. Topics will include the epidemiology and clinical picture of herpes zoster, with an emphasis on those with different immunocompromising conditions.
The safety and effectiveness of the vaccine Shingrix will be reviewed with a focus on those with immunocompromise.
Attendance to this webinar is eligible for 1 CPD point.